biote Corp

biote Corp

BTMD · NASDAQ · Healthcare / Medical Care Facilities

1.07USD+0.03 (+3.40%)

Price History

Full chart

Market Stats

Previous Close1.03
Open1.02
Day Range1.00 – 1.09
52-Week Range1.21 – 3.26
Volume65.39K
Market Cap41.70M
P/E (TTM)8.79
Forward P/E5.20
EPS0.14
Dividend Yield0.00%
Beta1.61
50-Day Avg1.72
200-Day Avg2.02

About

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and meet other administrative requirements; inventory management software to facilitate ordering and inventory control; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female patients. The company was founded in 2012 and is headquartered in Irving, Texas.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMr. Robert C. Peterson
  • Employees223
  • Headquarters1875 W. Walnut Hill Ln #100, Irving, TX, United States, 75038, USA
  • Websitehttps://www.biote.com

Leadership

  • Mr. Marc D. BeerExecutive Chairman · b. 1965
  • Mr. Robert C. PetersonInterim CEO, CFO & Chief Business Officer · b. 1977
  • Mr. John J. OlsenChief Information Officer · b. 1957
  • Mr. Dan MonicoGeneral Counsel
  • Mr. Joel PickeringChief Marketing Officer
  • Mr. Richard Kevin KeyChief Digital Officer · b. 1971
  • Mr. Jade BeutlerHead of Nutraceuticals · b. 1964
  • Dr. Cory Rice D.O.Chief Clinical Advisor & Member of Medical Advisory Board
  • Mr. Joey LopesSVP of Strategy & Commercial Operations
  • Dr. Komal Bajaj M.D., M.S.Chief Medical Officer

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue109.98M116.57M139.40M164.96M185.36M197.19M192.22M
Growth (%)-+5.99%+19.58%+18.34%+12.37%+6.38%-2.52%
Cost of Revenue43.56M44.93M48.82M54.58M57.88M58.13M54.86M
Gross Profit66.41M71.64M90.58M110.38M127.48M139.06M137.36M
Gross Margin60.39%61.46%64.98%66.92%68.78%70.52%71.46%
Operating Expense42.88M39.86M56.02M171.10M98.83M107.45M101.81M
Operating Income23.53M31.78M34.56M-60.72M28.66M31.61M35.55M
Operating Margin21.39%27.26%24.79%-36.81%15.46%16.03%18.50%
EBITDA24.29M32.91M35.98M7.96M39.54M15.59M52.22M
EBITDA Margin22.09%28.24%25.81%4.82%21.33%7.91%27.16%
Net Income21.29M29.16M32.62M-969.00K3.32M3.16M27.05M
Net Income Margin19.36%25.02%23.40%-0.59%1.79%1.60%14.07%
Interest Expense2.08M2.42M1.67M4.05M6.36M11.00M10.96M
Interest Expense % of Total Revenue1.89%2.08%1.20%2.45%3.43%5.58%5.70%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets23.89M32.59M54.33M111.64M155.29M122.37M107.61M
Total Liabilities56.82M49.66M50.20M169.92M191.84M224.57M158.01M
Total Equity-32.93M-17.07M4.13M-44.46M-29.40M-105.93M-58.54M
Cash10.49M17.21M26.77M79.23M89.00M39.34M24.12M
Total Debt47.13M42.35M37.34M120.43M114.87M110.86M109.92M
Net Debt36.65M25.15M10.57M41.20M25.87M71.52M85.80M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow25.35M26.43M33.72M-9.16M26.88M45.24M35.19M
Investing Cash Flow-1.67M-1.39M-3.81M-1.84M-2.71M-18.80M-6.86M
Financing Cash Flow-13.55M-18.32M-20.34M63.46M-14.38M-76.08M-43.55M
Capital Expenditure1.67M1.39M3.81M1.84M2.71M6.43M5.01M
Free Cash Flow23.68M25.03M29.91M-10.99M24.17M38.81M30.18M
Dividends Paid56.63M13.32M11.40M12.89M8.69M4.74M1.73M
FCF to OCF93.41%94.73%88.71%120.07%89.91%85.79%85.75%
Dividend Paid to FCF239.14%53.21%38.12%-117.20%35.97%12.22%5.72%

Earnings

Report DateAug 17, 2021Nov 24, 2021Dec 31, 2021May 20, 2022Aug 16, 2022Nov 14, 2022Mar 28, 2023May 9, 2023Aug 10, 2023Nov 7, 2023Mar 12, 2024May 7, 2024Aug 8, 2024Nov 12, 2024Mar 12, 2025May 7, 2025Aug 6, 2025Nov 5, 2025Mar 18, 2026May 6, 2026Aug 5, 2026Nov 4, 2026
EPS Estimate----0.140.140.140.090.100.080.080.100.260.200.090.130.130.050.090.080.03-0.05
EPS Actual0.230.08-0.03-0.032.01-1.740.18-0.39-0.250.250.180.320.320.180.100.140.160.220.070.080.10-
Surprise----1335.71%-1342.86%28.57%-533.33%-350.00%212.50%125.00%220.00%23.08%-10.00%11.11%7.69%23.08%340.00%-19.77%0.00%233.33%-
TimingAfter-hoursAfter-hours-After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap41.70M
Enterprise Value154.75M
Trailing P/E8.79
Forward P/E5.20
Price / Sales0.23
Price / Book2.96
EPS0.14
Book Value-2.38
Revenue (TTM)183.53M
Gross Profit (TTM)127.46M
EBITDA25.48M
Profit Margin3.19%
Operating Margin5.29%
Return on Equity0.00%
Return on Assets13.70%
Shares Outstanding28.68M
Shares Float16.47M
Beta1.61
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Strong Buy
Based on 6 analystsTarget 2.61
  • Strong Buy
    5
  • Buy
    1

Ownership Breakdown

Institutions
63.04%
Insiders
19.82%
Retail / Other
17.14%

Top Institutional Holders

  • 325 Capital LLC
    4.55M15.86%
  • Bandera Partners LLC
    2.07M7.20%
  • BlackRock Inc
    1.74M6.06%
  • Vanguard Capital Management, LLC
    1.11M3.88%
  • Acadian Asset Management LLC
    697.86K2.43%
  • State Street Corp
    646.95K2.26%
  • Geode Capital Management, LLC
    615.66K2.15%
  • Millennium Management LLC
    436.09K1.52%
  • Dimensional Fund Advisors, Inc.
    431.96K1.51%
  • Citadel Advisors Llc
    301.31K1.05%
  • Northern Trust Corp
    269.11K0.94%
  • Renaissance Technologies Corp
    265.92K0.93%
  • Rice Hall James & Associates, LLC
    262.84K0.92%
  • Morgan Stanley - Brokerage Accounts
    188.20K0.66%
  • Vanguard Portfolio Management, LLC
    166.60K0.58%
  • STRS OHIO
    166.30K0.58%
  • Vanguard Fiduciary Trust Co
    157.14K0.55%
  • Jacobs Levy Equity Management, Inc.
    151.05K0.53%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    829.70K2.89%
  • DFA US Small Cap I
    165.09K0.58%